Exclusive: Valeant to drop deal-making in near term to cut debt, boost stock

– Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making More...

Bill Ackman’s Pershing Square Gains Right To Solicit Special Meeting Of Allergan Shareholders Without Triggering Poison Pill In $51 Billion Takeover Battle

–   Lawyers for Allergan, Valeant Pharmaceuticals and Pershing Square yesterday announced they had mutually agreed to a common understanding, without waiting for a ruling by a Judge, that certain More...

Bill Ackman & Valeant File Hostile $51 Billion Exchange Offer For Allergan With SEC

– – Today Valeant Pharmaceuticals, in partnership with Bill Ackman and his Pershing Square activist hedge fund, went hostile in their endeavor to acquire speciality pharmaceuticals company Allergan, More...